Tags |
|
|
Links |
|
|
Advice You - Why and How to Avoid Bankruptcy
Avoiding bankruptcy no longer seems to be on most debtors’ lists of priorities and the number of recorded bankruptcies
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
is soaring. There were around 70,000 bankruptcies recorded in 2005 and about 45,000 of these were voluntary bankruptcie
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
s. This statistic clearly demonstrates the worrying fact that a large proportion of debtors see bankruptcy as a debt so
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
lution rather than as something to be avoided.
Bankruptcy trends are changing in a way that is concerning economists.
Bankruptcy trends are changing in a way that is concerning economists.
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
In the late 1990s the UK also experienced increasing bankruptcy rates. However, 60% of these bankruptcies were as a res
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ult of companies becoming insolvent. The picture is very different today as most bankruptcies are the result of individ
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ual insolvencies. In the fourth quarter of 2005 there were 20,461 bankruptcies which resulted from individual insolvenc
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ies. This figure represents an increase of 57% against the same period in 2004.
Although many people do not seem conce
Although many people do not seem conce
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rned about avoiding bankruptcy they really should do so if at all possible.
Avoiding bankruptcy is important b
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ecause of the penalties, disadvantages and stigmas that it carries.
Going bankrupt often means losing your home and yo
Going bankrupt often means losing your home and yo
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ur business and professional status. It also means that it is impossible to hold public office or form, manage or promo
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
te a company in the future.
Bankruptcy should also be avoided because it makes it very difficult to obtain cred
Bankruptcy should also be avoided because it makes it very difficult to obtain cred
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
it and your employment prospects can be prejudiced.
Avoiding bankruptcy is both advisable and possible with an
Avoiding bankruptcy is both advisable and possible with an
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
IVA. The government introduced IVAs in 1986 to help people to avoid bankruptcy.
An IVA is a binding agreement between
An IVA is a binding agreement between
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
a debtor and their creditors. The debtor agrees to repay their debts over a five year period via affordable monthly rep
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ayments. These monthly repayments can be as low as ?200.
In return, the creditors freeze interest on the debt, agree n
In return, the creditors freeze interest on the debt, agree n
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ot to contact the debtor while the IVA is in place and write off a proportion on the debt. It is not uncommon for as mu
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ch as 85% of a debt to be written off with an IVA.
After five years the debtor is deemed to be debt free. There are no
After five years the debtor is deemed to be debt free. There are no
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
disadvantages or penalties associated with an IVA. Furthermore, because an IVA is a private agreement between a debtor
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
and their creditors there is no stigma attached. As a result, an IVA is an excellent way of avoiding bankruptcy
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/91112/adviceyou-Why-and-How-to-Avoid-Bankruptcy.html">Why and How to Avoid Bankruptcy</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/91112/adviceyou-Why-and-How-to-Avoid-Bankruptcy.html]Why and How to Avoid Bankruptcy[/url]
Related Articles:
The Law of Attraction In Business
Strategic Planning Begins With Mission and Vision Statements
How To Make Money With Google Adsense (Part 2)
Bookmark it:
|